Personalized Medicine for the Management of RDS in Preterm Neonates
Daniele De Luca, Chiara Autilio, Lucilla Pezza, Shivani Shankar-Aguilera, David G Tingay, Virgilio P Carnielli
NEONATOLOGY | KARGER | Published : 2021
Continuous positive airway pressure and surfactant represent the first- and second-line treatment for respiratory distress syndrome in preterm neonates, as European and American guidelines, since 2013 and 2014, respectively, started to recommend surfactant replacement only when continuous positive airway pressure fails. These recommendations, however, are not personalized to the individual physiopathology. Simple clinical algorithms may have improved the diffusion of neonatal care, but complex medical issues can hardly be addressed with simple solutions. The treatment of respiratory distress syndrome is a complex matter and can be only optimized with personalization. We performed a review of..View full abstract
Awarded by National Health and Medical Research Council Clinical Career Development Fellowship
A/Prof. Tingay is supported by a National Health and Medical Research Council Clinical Career Development Fellowship (Grant ID 1053889) and the Victorian Government Operational Infrastructure Support Program (Melbourne, Australia). The funder did not participate in the work.